HIA
NTLA icon

Harbor Investment Advisory’s Intellia Therapeutics NTLA Stock Holding History

Harbor Investment Advisory’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23K Hold
250
– – ﹤0.01% 1146
2026
Q1 		$3.21K Hold
250
– – ﹤0.01% 1076
2025
Q4 		$2.25K Buy
250
+100
+67% +$1.38K ﹤0.01% 1130
2025
Q3 		$2.59K Hold
150
– – ﹤0.01% 1079
2025
Q2 		$1.41K Hold
150
– – ﹤0.01% 1106
2025
Q1 		$1.07K Hold
150
– – ﹤0.01% 1114
2024
Q4 		$1.75K Sell
150
-1,650
-92% -$25.8K ﹤0.01% 1073
2024
Q3 		$37K Hold
1,800
– – ﹤0.01% 652
2024
Q2 		$40.3K Hold
1,800
– – ﹤0.01% 619
2024
Q1 		$49.5K Sell
1,800
-200
-10% -$5.55K 0.01% 585
2023
Q4 		$61K Hold
2,000
– – 0.01% 525
2023
Q3 		$63.2K Sell
2,000
-20
-1% -$776 0.01% 497
2023
Q2 		$82.4K Hold
2,020
– – 0.01% 557
2023
Q1 		$75.3K Sell
2,020
-800
-28% -$31.4K 0.01% 582
2022
Q4 		$98.4K Sell
2,820
-400
-12% -$19K 0.02% 498
2022
Q3 		$180K Buy
3,220
+300
+10% +$18.6K 0.03% 351
2022
Q2 		$151K Hold
2,920
– – 0.02% 390
2022
Q1 		$212K Sell
2,920
-1,950
-40% -$165K 0.03% 367
2021
Q4 		$576K Sell
4,870
-1,540
-24% -$193K 0.07% 203
2021
Q3 		$860K Buy
6,410
+5,210
+434% +$789K 0.12% 151
2021
Q2 		$194K Buy
1,200
+900
+300% +$70.1K 0.03% 376
2021
Q1 		$24K Buy
+300
New +$20.1K ﹤0.01% 853
2020
Q1 		– Sell
-500
Closed -$7K – 1138
2019
Q4 		$7K Buy
+500
New +$6.96K ﹤0.01% 676

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Harbor Investment Advisory's NTLA Position: Q2 2026 in Review

Harbor Investment Advisory held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 250 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

Harbor Investment Advisory first reported a position in NTLA in Q4 2019 and has held it in 23 quarters since. The position peaked at $860K in Q3 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Harbor Investment Advisory held 250 shares of Intellia Therapeutics worth $4.23K as of Q2 2026.
  • Harbor Investment Advisory left its Intellia Therapeutics share count unchanged in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1146 holding.
  • Harbor Investment Advisory first reported a position in Intellia Therapeutics in Q4 2019 and has held it in 23 quarters since.
  • Harbor Investment Advisory's Intellia Therapeutics position peaked at $860K in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.